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Abstract
MicroRNAs (miRNAs) are endogenously expressed single-stranded ,21–23 nucleotide RNAs that inhibit gene expression
post-transcriptionally by binding imperfectly to elements usually within the 39untranslated region (39UTR) of mRNAs. Small
interfering RNAs (siRNAs) mediate site-specific cleavage by binding with perfect complementarity to RNA. Here, a cell-based
miRNA reporter system was developed to screen for compounds from marine and plant extracts that inhibit miRNA or siRNA
activity. The daphnane diterpenoid genkwanine M (GENK) isolated from the plant Wikstroemia polyantha induces an early
inflammatory response and can moderately inhibit miR-122 activity in the liver Huh-7 cell line. GENK does not alter miR-122
levels nor does it directly inhibit siRNA activity in an in vitro cleavage assay. Finally, we demonstrate that GENK can inhibit
HCV infection in Huh-7 cells. In summary, the development of the cell-based miRNA sensor system should prove useful in
identifying compounds that affect miRNA/siRNA activity.
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Introduction
MicroRNAs (miRNAs) are small endogenous non-coding single-
stranded RNAs (typically 21–23 nucleotide long) that act
posttranscriptionally to repress translation [1–5] and/or induce
mRNA decay [6–8]. miRNAs play significant roles in a number of
cellular processes and their misregulation has been linked to many
pathological states, including cancer [9,10], diabetes [11,12],
neurodegenerative disease [13] and viral infections [14–16]. To
date, over 1900 unique mature miRNA sequences have been
identified in Homo sapiens, indicating a widespread role in gene
regulation (miRBase release 18, microrna.sanger.ac.uk). miRNAs
inhibit translation by binding imperfectly to sequences within the
39 untranslated region (39UTR) of specific messenger RNAs
(mRNAs) [17,18]. By contrast, small interfering RNAs (siRNAs),
which are produced by introducing foreign dsRNAs [19] or by
endogenously transcribed double-stranded RNAs (dsRNAs) [20],
bind to RNA sequences with perfect complementarity leading to
specific cleavage and subsequent degradation of the target mRNA.
The introduction of dsRNAs or siRNAs is extensively used by
many researchers to knock down the expression of mRNAs, a
process called RNA interference (RNAi) [19].
Initially, most miRNAs are transcribed by RNA polymerase II
as a long primary miRNA transcript (pri-miRNA) [21] which is
capped and polyadenylated [22]. The pri-miRNA, which can
contain clusters of miRNAs, is processed by the RNAase III
enzyme Drosha [23] and the dsRNA binding protein, DGCR8
[24], into precursor miRNAs (pre-miRNAs) in the nucleus. The
pre-miRNA folds into a stem loop structure and is recognized and
exported to the cytoplasm by Exportin 5 [25–27]. The ,70
nucleotide pre-miRNA is then processed by another RNAse III
enzyme, Dicer [28–30], and its binding partner, TRBP [31,32],
into a mature 21–23 nucleotide dsRNA containing 2 nucleotide 59
overhangs. The dsRNA is delivered to the RNA-inducing silencing
complex (RISC), which contains an Argonaute (Ago) protein
[31,33–35]. One of the strands of the dsRNA (the guide strand)
remains with the RISC complex; selection is determined by the
most stable 59 end of the duplex [36,37]. The miRNA-containing
RISC complex binds to the target sequence within the 39UTR of
the mRNA [38]. If the miRNA pairs with the target sequence with
perfect complementarity, the target sequence undergoes endonu-
cleolytic cleavage specifically by Ago2 and the mRNA is
subsequently degraded [39]. By contrast, most miRNAs pair with
imperfect complementarity leading to translational repression
and/or degradation of the mRNA [38]. The mechanism by which
miRNAs exert translational repression remains controversial [40].
Several models have been proposed including miRNA-directed
inhibition of the cap-binding complex, inhibition of translation
elongation, and deadenylation stimulation leading to subsequent
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39621degradation of target mRNA. Besides the main miRNA biogenesis
pathway described, a subset of miRNAs mature via alternate
pathways including Drosha-independent and Dicer-independent
pathways and can originate from tRNA precursors and introns
[41,42].
The maturation of miRNAs can be regulated at the transcrip-
tional and post-transcriptional levels and are impacted by distinct
signaling pathways. Specifically, miRNA biogenesis can be
regulated at distinct steps thus altering the rate at which pri-,
pre- and mature miRNAs are processed. For instance, Drosha
activity can be regulated positively and negatively to affect pri-
miRNA maturation. Drosha-mediated processing of the pri-
miRNA let-7 can be blocked by lin-28 [43]. Furthermore,
estradiol stimulation can inhibit pri-miRNA processing of a subset
of miRNAs by inducing estrogen receptor-a interactions with
Drosha [44]. By contrast, it has been shown that TGF-b signaling
pathway can promote the processing of pri- to pre-miRNA of
miR-21 through Smad association with Drosha [45]. KSRP, an
RNA binding protein known for its role as a splicing factor, is also
a component of Dicer and Drosha complexes and is involved in
the biogenesis of a subset of miRNAs [46]. Dicer activity can be
regulated by the MAP/ERK kinase pathway via phosphorylation
of its binding partner TRBP [47]. Finally, RISC activity can be
targeted. Growth factor treatment of cells enhance the stability of
Ago2, thus effectively promoting global miRNA and siRNA
activities [48].
Chemical biology approaches have provided insights into the
signaling pathways that control miRNA activity. Enoxacin, which
was discovered via a cell-based high-throughput screen, enhances
siRNA-mediated suppression of a target mRNA, and promotes
miRNA biogenesis by acting at the TRBP-mediated stage [49,50].
In other studies, a modified azobenzene compound was identified
to specifically inhibit miR-21 activity by targeting pri-miRNA
transcription [51] and small molecules have been found to
modulate the liver-specific miR-122 levels [52]. In addition,
Watashi et al. (2010) discovered two compounds, polylysine and
trypaflavine, that inhibit Dicer and Argonatute activity, respec-
tively [53]. Such studies can generate valuable tools for elucidating
regulatory and signaling pathways of miRNA/siRNA function and
may provide lead compounds for treatment of miRNA-associated
diseases. In this study, we have used a cell-based high-throughput
approach to screen for compounds from marine and plant extracts
that inhibit miRNA/siRNA activity. We have identified a
compound of the Daphne diterpenoid family - called genkwanine
M (GENK) [54]- which affects diverse cellular functions including
the inhibition of miRNA activity.
Results
Identification of Chemical Inhibitors of miRNA Activity
To identify compounds that interfere with miRNA and siRNA
regulation and/or processing, we screened natural products using
a cell-based reporter system that monitors miRNA and siRNA
activity. A stably transfected clonal HeLa cell line expressing a
reporter RNA encoding the eGFP gene and a sequence that bears
perfect complementarity to the let-7a miRNA within the 39UTR
(CMV-GFP-let-7) was generated (Figure 1A). Under basal
conditions, endogenously-expressed let-7a binds to the comple-
mentary sequence leading to Ago2-mediated cleavage of the
reporter RNA resulting in low GFP expression (Figure 1B). By
contrast, transfection of an antisense 29-O-methyl let-7 (AS-let-7)
but not a randomized antisense RNA (AS-Ran) resulted in GFP
expression, indicating that GFP expression is under the control of
let-7a (Figure 1B). Using this cell-based reporter system, a library
of crude marine and plant extracts (,12,000) was screened and
four crude extracts were identified that led to an increase in GFP
expression (Figure 1B). Specifically, we searched for extracts that
led to a .3 fold increase GFP expression over background which
is similar to that observed when cells were transfected with the AS-
let-7. Guided by the reporter GFP system, sequential fractionation
of one of the extracts led to the isolation of genkwanine M
(GENK) (Figure 2A). Unfortunately, the other three extracts did
not yield a pure compound. As a result, we focused on the
characterization of GENK and its cellular effects.
Isolation of GENK
The plant extract containing GENK was prepared from the
leaves and twigs of a 0.5 m tall shrub of Wikstroemia polyantha
(family Thymelaeaceae), collected on the centerline of Peninsula
Malaysia approximately 50 miles south of the Thai border by
E. Soepadmo and M. Suhaimi under contract with the University
of Chicago at Illinois. A voucher numbered Q66O4184 was
deposited in the Field Museum in Chicago and at the National
Herbarium at the Smithsonian. The plant material was transferred
to the NCI Open Repository where it was dried and then
extracted with CH2Cl2 and MeOH. The crude extract was
entered into the Open Repository screening plates as sample
number NO44759. Three grams of the crude extract were
supplied to UBC by D. Newman of the NCI Open Repository.
Detailed procedures on the isolation and purification of GENK
are described in the Materials and Methods and in the
Supplementary Materials S1.
Elucidation of GENK Structure
GENK (Figure 2A) gave a [M+Na]
+ ion at m/z 613.2421 in the
HRESIMS consistent with a molecular formula of C34H38O9
(calcd for C34H38O9Na, 613.2414), requiring 16 sites of unsatu-
ration. The diterpenoid constitution and most of the relative
configuration of GENK was determined by detailed analysis of 1D
and 2D NMR data (Supplemental Materials S1). However, some
of the relative configurations in the region C-1 to C-7 could not be
assigned with certainty from the NMR data. Therefore, GENK
(Figure 2A) was converted to its diacetyl derivative (Figure 2B) (see
Supplemental Materials S1 for NMR and MS data), which gave
crystals from a 9:1 CCl4/hexane solution that were suitable for
single crystal x-ray diffraction analysis. An ORTEP diagram that
shows the constitution and absolute configuration of the diacetyl
derivative is shown in Figure 2B (Supporting Materials S1).The
NMR data obtained for GENK showed no evidence for the
presence of acetate groups, indicating that the structure of the
natural product as shown in Figure 2A, which is identical to that
reported for the daphnane diterpenoid genkwanine M [54].
GENK Effects on miRNA Activity
To confirm the effects of GENK on let-7a, CMV-GFP-let-7
reporter RNAs were monitored by Northern blot analysis.
Treating CMV-GFP-let-7-expressing HeLa cells with GENK at
1 and 10 mg/mL (1.7 mM and 17 mM) increased the levels of GFP
RNA by approximately two fold, similar to that observed when
cells were transfected with AS-let-7 but not AS-RAN (Figure 3A).
To determine whether this effect is specific to let-7 in HeLa cells,
GENK was tested in Huh-7 hepatocarcinoma cells stably
transfected with the CMV-GFP-miR-122 reporter. miR-122 is
highly expressed in Huh-7 cells, representing ,70% of all
miRNAs expressed in this cell line [55,56]. Similar to that
observed in HeLa cells, GENK treatment resulted in an increase
in GFP RNA with an EC50 of 8.3 mg/mL or 14 mM (Figure 3B).
In addition, a minor product in the extracts, which was identified
Cellular Effects of Genkwanine M
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Supplemental Materials S1) was determined to be 70% as active as
GENK (Figure 3C) in the stably expressing CMV-GFP-miR-122
Huh-7 cell line. Treatment of HeLa and Huh-7 cells with 10 mM
GENK for up to 24 or 48 hours did not significantly affect cell
proliferation or viability as measured by the MTT assay
(Supplementary Figure S1). Due to the consistent effects of GENK
observed in the stably-transfected Huh-7 cells, we focused on this
cell line for the remainder of the study.
To determine if GENK specifically inhibits siRNA activity, we
tested if GENK can alter GFP mRNA levels in Huh-7 cells stably
expressing a reporter RNA lacking the miR-122 binding site
Figure 1. Cell-based assay for the identification of small molecule miRNA inhibitors. (A) Schematics of CMV and eEF1a promoter-driven
expression plasmids that contain the eGFP or Renilla luciferase (RL) reporter gene alone or with a perfectly complementary binding site for let-7a or
for miR-122 (black rectangle). (B) Stably transfected HeLa cells expressing CMV-GFP-let-7 were incubated with a series of plant or marine extracts for 8
hours or transfected with 29 O-methyl antisense let-7 (AS-let-7) or random RNAs (AS-Ran) for 2 days. Cells were subsequently fixed and stained with
Hoechst dye, and imaged by a high-throughput microscope (Cellomics). Representative images are shown of cells treated with a positive or negative
extract and of cells transfected with AS-let-7 or AS-Ran.
doi:10.1371/journal.pone.0039621.g001
Figure 2. Structure of (A) genkwanine M (GENK), (B) diacetyl GENK, and (C) genkwanine P. (B) Diacetyl GENK was prepared from GENK by
treatment with acetic anhydride and DMAP in anhydrous THF.
doi:10.1371/journal.pone.0039621.g002
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an increase in GFP RNA levels in this cell line (Figure 3E, 3F),
indicating that GENK may act at the level of transcription and not
through miR-122. However, closer examination of the kinetics of
the increase in reporter RNA levels during GENK treatment
showed that GENK has a specific impact on the reporter mRNA
containing the miR-122 binding site (Figure 3D, 3E). GENK
treatment of CMV-GFP-miR-122 cells led to an increase in GFP
RNA levels that peaked at 2 hours after treatment and then
decreased over the next 6–8 hours (Figure 3D). By contrast,
GENK treatment of CMV-GFP expressing cells resulted in a
gradual increase in reporter RNA levels that continued to increase
8–10 hours after treatment (Figure 3E). Plotting the reporter
mRNA levels (normalized to GAPDH mRNA levels) showed that
GENK treatment stimulated the increase of CMV-GFP-miR-122
mRNA levels more quickly than that of the CMV-GFP mRNA
levels, suggesting that miR-122 activity is temporally inhibited
during GENK treatment (Figure 3F). To explore this further, we
constructed expression plasmids containing different promoters.
We selected the SV40 promoter. We constructed an SV40-Renilla
Figure 3. GENK effects on reporter RNA levels. (A) eGFP-let-7 mRNA levels in HeLa cells incubated with GENK for 6 hrs or transfected with AS-
let-7 or AS-Ran 29-O-methyl RNAs for 2 days. (B, C) eGFP-miR-122 mRNA levels in Huh-7 cells treated with either (B) GENK or (C) GENK P for 2 hours at
the indicated concentrations (10 mM for (C)). (D, E) eGFP-miR-122 (D), eGFP (E), and GAPDH mRNA levels in Huh-7 cells treated with 10 mM of GENK for
the indicated time. (F) Quantitation of eGFP-miR-122 and eGFP mRNA levels normalized to GAPDH from (D) and (E). (G) RL and RL-miR-122 reporter
mRNA levels in Huh-7 cells treated with 10 mM GENK for the indicated times. (H) Quantitation of RL and RL-miR-122 mRNA levels normalized to
GAPDH from (G). At 6 and 8 hours GENK treatment, the RL-miR-122 mRNA levels were ,1.2 fold higher than the RL mRNA levels (6 hours, p-
value=0.0192; 8 hours, p-value=0.055). For each experiment, cells were transiently transfected with the indicated reporter plasmids for 24 hours
before GENK treatment. Shown are representative Northern blots from at least three independent experiments.
doi:10.1371/journal.pone.0039621.g003
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ry Figure S2A). After 6 hours of GENK treatment in Huh-7 cells,
the SV40 promoter constructs were induced 1.3 fold and 1.8 fold
in the absence and presence of the miR-122 site, respectively,
which is a similar induction observed with the CMV-RL construct
(Supplementary Figure S2B, S2C). Thus, GENK treatment
induced expression from both CMV- and SV40-driven reporter
constructs. To separate the promoter and miRNA effects by
GENK, we constructed an expression plasmid containing the
eukaryotic elongation factor 1A (eEF1A) promoter (Figure 1A),
which is predicted to direct transcription constitutively [57]. We
transiently transfected either eEF1A-Renilla-miR-122 (eEF1a-RL-
miR-122) or eEF1A-Renilla (eEF1a-RL) (Figure 1A) expression
plasmids into Huh-7 cells and monitored reporter RNA levels after
GENK treatment. In eEF1A-RL transfected Huh-7 cells, reporter
RNA levels remained constant for 8 hours of 10 mM GENK
treatment, demonstrating that unlike that observed with the
CMV- and SV40-promoter driven reporters, GENK had minimal
effects on the transcription from the eEF1A promoter (Figure 3G,
3H). For the eEF1a-RL-miR-122 construct, GENK reproducibly
increased reporter RNA levels to a minor extent (1.2 fold) after 4
to 8 hours of treatment (Figure 3G, 3H). Thus, GENK can both
stimulate CMV and SV40-promoter-dependent transcription and
inhibit miR-122 activity.
GENK does not Affect miRNA Levels
Given that GENK inhibited miRNA activity, we explored the
possibility that it might affect miRNA levels. Total RNA from cells
treated with GENK was isolated and loaded on a high percentage
acrylamide gel to resolve miRNAs [58]. Northern blotting showed
that mature miR-122 levels in Huh-7 cells (Figure 4A) and mature
let-7a levels in HeLa cells (Figure 4B) were not affected during
GENK treatment, suggesting that GENK may affect miRNA
activity directly rather than the transcription or stability of
miRNAs. To investigate this, we tested whether GENK can
inhibit miRNA-dependent cleavage in an in vitro assay. Towards
this, an in vitro transcribed reporter RNA, containing a perfectly
complementary site for miR-451 or a miR-451 site in the reverse
complement direction, was incubated in rabbit reticulocyte lysates
(RRL) (Supplementary Figure S3A). miR-451 is highly expressed
in RRL [59]. Specific cleavage of the reporter RNA (388
nucleotides) directed by miR-451 resulted in a 322 nucleotide
RNA fragment (Supplementary Figure S3A). Incubation of the 59-
[
32P]-labeled reporter RNA containing the complementary miR-
451 but not the reverse complement miR-451 sequence resulted in
specific cleavage of the reporter RNA (Supplementary Figure S3B,
10 minute incubation). Addition of 10 mM GENK to the extracts
did not alter the rate of cleavage of the reporter RNA
(Supplementary Figure S3B). Several conditions were tested in
which GENK was preincubated with the extract prior to addition
of the reporter RNA and GENK was incubated at different
concentrations and for longer times, none of which altered the
cleavage rate (data not shown). In summary, these data suggests
that GENK treatment does not inhibit the maturation of miRNA
or affect miRNA or siRNA activity as monitored by an in vitro
cleavage assay.
GENK Induces an Inflammatory Response
The observation that GENK treatment stimulated CMV
transcription, but not eEF1A-driven transcription suggests
GENK may stimulate transcription of a subset of genes. To
explore this further, we profiled the transcriptome of Huh-7
cells treated with GENK for 1 and 4 hours using microarray
analysis. GENK induced the expression of 0.07% (32 mRNAs)
and 0.17% (94 mRNAs) of total mRNAs by 2-fold or more at 1
and 4 hours GENK treatment respectively (Figure 5A, 5B) (p-
value ,0.01, BH-adjusted). Based on the two time points,
several trends in gene expression are observed. One, a
significant subset of mRNAs (23%) are up-regulated at both 1
and 4 hours GENK treatment (Supplementary Figure S4).
Second, a small number of mRNAs were significantly down-
regulated in GENK-treated cells (13 mRNAs at 4 hours)
(Supplementary Figure S4). Third, the majority of mRNAs did
not change significantly during GENK treatment (,2 fold).
Supplementary Tables S1 and S2 display the top mRNAs that
are up or down-regulated by more than 2 fold under GENK
treatment for 1 and 4 hours, respectively. Supplementary Table
S3 displays the top mRNAs that are up-regulated more than 2
fold at both 1 and 4 hours GENK treatment. The majority of
genes include chemokines/cytokines, proteins involved in signal
transduction pathways, and transcription factors or modulators.
The genes induced after 1 hour GENK treatment closely
matched the chemokines and cytokines induced by TNFa
stimulation in 3T3 fibroblasts in a study published by Hao and
Baltimore (2009) (Supplementary Table S1 and S2) [60].
Furthermore, classic early immediate genes described in that
study such as c-Fos,c - Jun, Irf1, Cscl2 and Ier3 [60] were induced
during GENK treatment. Thus, the results indicate that GENK
treatment induces an early inflammatory response.
To confirm these results, we monitored Fos and Jun mRNA
levels during GENK treatment. Unlike GAPDH mRNA levels,
Fos and Jun (Figure 5D, 5E) mRNA levels were transiently up-
regulated within the first few hours of GENK treatment before
decreasing at later time points, in agreement with previous reports
and the microarray analysis, and consistent with the idea that
GENK treatment induces the early inflammatory response [60].
The transient induction of Fos and Jun (Figure 5D, 5E) mRNA
Figure 4. GENK effects on mature miRNA levels. Mature miR-122
levels (A) or let-7a miRNA levels (B) in Huh-7 and HeLa cells,
respectively, treated with 10 mM GENK for the indicated times. Shown
are representative Northern blots from at least three independent
experiments.
doi:10.1371/journal.pone.0039621.g004
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reporter CMV-GFP-miR-122 mRNA levels (Figure 3D, 3F).
TNFa Inhibits miR-122 Activity
Given that GENK treatment activated the inflammatory
response and also inhibited miR-122 and let-7 miRNA, we
investigated whether a well-established inducer of the inflam-
matory response, TNFa, has an effect on miRNA inhibition.
Huh-7 cells were transiently transfected with eEF1a-RL and
eEF1a-RL-122 and then treated with 10 ng/mL TNFa. Under
this treatment, the reporter RNA increased to the same degree
and had similar kinetics as that observed with cells treated with
GENK (Figure 6). As shown previously, TNFa treatment
resulted in an increase in Fos mRNA [60]. Thus, these results
suggest that GENK and TNFa activate a similar response,
which includes a moderate inhibition of miRNA activity and
induction of CMV-driven transcription (Figure 6).
Figure 5. Transcriptional response elicited by GENK treatment. (A and B) Scatter plots of microarray-derived mRNA expression in Huh-7 cells
treated with DMSO or 10 mM GENK for (A) 1 or (B) 4 hours. At the indicated times, total mRNA was isolated and analyzed as described in the
Experimental Section. Normalized relative hybridization signal intensities of GENK treatment (x-axis) versus DMSO treatment (y-axis) are plotted. The
data values are highly correlated (Pearson correlation 0.995 for 1 hour treatment and 0.991 for 4 hours treatment). Dotted black lines correspond to 2-
fold change (up or down-regulation). (C) Venn diagram of genes up-regulated at least 2-fold after 1 and 4 hours GENK treatment. (D) Fos and Jun
mRNA levels in Huh-7 cells treated with 10 mM GENK for the given times are shown by northern blot analysis. (E) Quantitation of mRNA levels from (D)
normalized to GAPDH mRNA levels.
doi:10.1371/journal.pone.0039621.g005
Cellular Effects of Genkwanine M
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miR-122 is necessary for Hepatitis C virus (HCV) replication in
Huh-7 cells [14]. Given our observations that GENK induces the
inflammatory response and moderately inhibits miR-122 activity,
we tested whether GENK may inhibit HCV replication. Infection
of Huh-7 cells by the infectious HCV clone, JFH-1, at low
multiplicity of infection (MOI of 0.25 to 1.0) resulted in ,4–15%
of the cells showing fluorescence by antibody staining to the HCV
core protein at 2 day post-infection (Figure 7). By contrast,
addition of GENK significantly decreased the percent of cells
infected by HCV. At an MOI of 1, GENK inhibited HCV
infection by approximately 3 fold (Figure 7). Thus, GENK
treatment can inhibit HCV infection in Huh-7 cells.
Discussion
MiRNAs play important roles in cellular homeostasis, develop-
ment, and disease. Despite the discovery of the main factors
involved in miRNA biogenesis, the regulation and signaling
pathways that impact miRNA maturation and function are poorly
understood. In this study, we have used a miRNA-sensitive
reporter cell line to identify a small molecule from a collection of
plant and marine extracts that induces the early inflammatory
response and moderately inhibits miRNA function. Using reporter
constructs, we demonstrated that GENK inhibits miRNA-
mediated repression in a time-dependent manner, thus suggesting
that tight control of miRNA activity is involved in the early
inflammatory response.
Gene profiling revealed that GENK treatment of Huh-7 cells
induced an early inflammatory response as several signature
markers such as Fos and Jun mRNA levels are increased early
during GENK treatment of cells (Supplementary Table S1 and S2,
Figure 5). The expression profiles of GENK-treated cells are
remarkably similar to those of TNFa treated cells. It has been
shown that the early inflammatory response mediated by cytokines
such as TNFa is regulated by transcription factors such as NF-kB,
AP-1 and interferon-regulatory factors [60]. The CMV and SV40
promoters contain binding sites for the transcription factors NF-kb
and AP-1 [61,62]. Thus, the activation of the CMV and SV40-
driven reporter constructs by GENK treatment in our studies is
likely due to the induction of an inflammatory response via NF-kb
and AP-1 signaling.
Both TNFa and GENK treatments lead to a rapid increase of
Fos and Jun mRNAs followed by rapid degradation (Figure 5)
[60]. This early burst of expression is mediated by several
mechanisms including transcriptional induction and increased
mRNA stability through AU-rich elements (AREs) in the 39UTR.
Early immediate genes such as Fos and Jun contain 39UTR AREs
which destabilize mRNAs under basal conditions. In response to
external signals such as ionizing radiation or immune signaling,
ARE-mediated decay is inhibited for a short time to allow
stabilization of and translation of ARE-containing mRNAs [60].
Prolonged or chronic misregulation of this posttranscriptional
response can lead to inflammatory disorders and disease. For
example, targeted deletion of the ARE in TNFa in mice leads to
chronic inflammatory arthritis and Crohn’s-like inflammatory
bowel disease [63]. Interestingly, a previous study reported that
the miRNA pathway may play a role in regulating the stability of
Figure 6. Treatment of cells with TNFa. (A) Northern blot analysis of reporter Renilla luciferase (RL) and RL-miR-122 mRNA levels in Huh-7 cells
treated with 10 ng/mL of TNFa for the indicated times. Huh-7 cells were transiently transfected with eEF1A-RL or eEF1A-RL-122 plasmids for 24 hours
before TNFa treatment. (B) Quantitation from (A) of at least three independent experiments. At 4 hours TNFa treatment, the RL-miR-122 mRNA levels
were ,1.2 fold higher than the RL mRNA levels (p-value=0.012).
doi:10.1371/journal.pone.0039621.g006
Figure 7. Inhibition of HCV replication in Huh-7 cells by GENK.
Huh-7 cells were mock-infected or infected with HCV at a MOI of 0.25,
0.5, or 1 in the presence of DMSO or 10 mM GENK. DMSO or GENK was
added 24 hrs prior to infection and subsequently every 24 hrs. 48 hrs
post-infection, cells were fixed then probed with an HCV-core protein
specific antibody and cell nuclei were stained with Hoechst dye. The
percentage of HCV infected cells (positive for core expression) was
determined by immunofluorescence using a high-throughput micro-
scope (Cellomics). At a MOI of 0.5 and 1, 10 mM GENK treatment
inhibited HCV infection as compared to DMSO treatment (p-value
,0.0001). There was no difference in the percentage of cells with
immunofluorescence above background in mock-infected or HCV-
infected cells (MOI 0.25) treated with DMSO or 10 mM GENK (p-
value=0.2918 and p-value=0.2484, respectively).
doi:10.1371/journal.pone.0039621.g007
Cellular Effects of Genkwanine M
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RNA interference [8,64]. In our study, we have shown that
miRNA-dependent repression can be inhibited by GENK
treatment, albeit to moderate levels. The level of repression was
reproducible and consistently ,1.2 fold using reporter constructs
under the control of the constitutive eEF1A promoter (Figure 3G,
3H). Although the repression was moderate, there was a significant
impact on the kinetics of expression of reporter constructs driven
by the CMV promoter. In the miRNA-regulated reporter CMV-
GFP-miR-122 construct, the reporter RNA levels peaked at 2
hours before decreasing (Figure 3D, 3F), which is a pattern similar
to that observed with other classic early response genes such as Fos
and Jun during an inflammatory response (Figure 5D) [60]. By
contrast, the CMV-GFP reporter RNA lacking a miRNA binding
site showed a gradual increase in expression over time (Figure 3E,
3F). This strongly indicates that miR-122-mediated repression of
the CMV-driven reporter construct is inhibited during GENK
treatment to allow for the rapid increase in reporter mRNA levels.
These results support the idea that the combination of miRNA-
mediated repression, albeit minor, and transcriptional induction
during GENK treatment contribute to the tight regulation of
genes during the inflammatory response, possibly those mRNAs
containing AREs.
GENK does not alter mature let-7a or miR-122 levels,
suggesting that the inhibition of miRNA activity is likely at the
level of RISC activity (Figure 4). GENK does not affect siRNA-
mediated cleavage in an in vitro cleavage assay. How GENK
inhibits miRNA/siRNA activities in vivo remains to be investigated.
Given the pleiotropic effects of GENK, it seems likely that
inhibition of miRNA activity is a result of the induction of the
inflammatory response.
GENK inhibits HCV virus infection in Huh-7 cells (Figure 7),
which is likely due to activation of an inflammatory response and
to a minor extent inhibition of miR-122 activity by GENK.
Previously, it has been reported that HCV replication is resistant
to TNFa [65]. Thus, despite similarities of the effects tested in this
study by GENK and TNFa, GENK may be inhibiting HCV virus
infection specifically and distinct of the effects observed by TNFa.
Chemical biology approaches provide an alternative to genetic
screens in identifying signaling pathways that affect major
biological processes. The use of reporter constructs that sense
miRNA or siRNA activity has been extremely useful for
identifying chemical inhibitors of this pathway [49–52]. Although
the CMV and SV40 promoters are strong transcriptional
promoters and have been used widely for expression studies,
these promoters are highly inducible especially during signaling
events that activate an inflammatory response [57,61,62]. The use
of a constitutive promoter such as the eIF1A promoter used in this
study should be useful for future screenings of chemical inhibitors
of miRNA function.
Methods
Plasmids
CMV-GFP-let-7 and CMV-eGFP-miR-122 were constructed
by inserting a perfectly complementary let-7 or miR-122 binding
site within an MfeI restriction enzyme site between the eGFP and
SV40 poly A signal in pEGFP-N1 vector (Clontech). eEF1A-RL
and eEF1A-RL-miR-122 were constructed by swapping the CMV
promoter of CMV-GFP-let-7 or CMV-GFP-miR-122 with the
eEF1A promoter from pTy-eGFP (kindly provided by Ivan
Sadowski, University of British Columbia) using the restriction
site BglII and HindIII. eEF1a-RL-122 was constructed by PCR
with primers containing an Nhe1 site with the initial ORF of RL
and a primer containing the end of the reverse complement ORF
of RL, miR-122 binding site and XbaI site. This fragment was
subsequently swapped into the eEF1a-RL, replacing the RL with
NheI and XbaI restriction sites. SV40-RL (provided by Martin
Bushell, University of Notingham) was used as a template to
construct SV40-RL-miR122 and CMV-RL. Specifically, SV40-
RL-miR122 was constructed by introducing miR122 into the
Xba1 site. And CMV-RL was made by swapping in SV40
promoter with full length CMV promoter (from pCDNA3,
Invitrogen) using BglII and HindIII restriction sites.
Cell Culture and Stable Cell Lines
HeLa and Huh-7 cells were grown in Dulbecco’s modified
Eagle medium (DMEM) (Sigma) with 10% fetal bovine serum (v/
v) (Hiclone), 2 mM L-glutamine (Invitrogen), and 50 mg/mL
penicillin/streptomycin (Invitrogen). HeLa and Huh-7 cells were
obtained by stocks held at Stanford University, Stanford,
California, from previous studies [14,66]. Stable cell lines were
selected by transfection with Lipofectamine 2000
TM (Invitrogen)
and using 1 mg/mL Geneticin (Invitrogen). All of the cells were
maintained at 37uCi n5 %C O 2.
Screen for miRNA Inhibitors
HeLa cells stably expressing EGFP-let-7 by CMV promoter
were seeded in PerkinElmer View 96-well plates at 8,000 cells per
well in 100 mL DMEM at 37uC. 24 hours after seeding, 340 nL of
marine and plant extracts were added to each well using a
Biorobotics Biogrid II equipped with a 0.7 mm diameter 96-pin
tool. Plates were incubated for 8 hours at 37uC, the medium was
aspirated and cells were fixed with 3% paraformaldye in PBS for
15 min at room temperature. After two washes with PBS, the cells
were incubated with 500 ng/mL Hoechst 33342 for 15 min at
room temperature. Plates were read in a Cellomics
TMArrayscan
VTI automated fluorescence imager. Cells were photographed
with a 106 objective in the Hoechst and FITC (XF-93 filter)
channels. 10 images per well were collected. The target activation
analysis algorithm was used to identify cells via Hoechst stain of
the nuclei (ObjectAreaCh1=5) in the first channel and apply a
cytoplasmic mask in the second FITC channel around the nucleus.
This allows us to determine the average cytoplasmic GFP intensity
of each cell. The average GFP intensity of all the cells in each well
was computed at fixed 200 pixel intensity units. Guided by the AS-
let-7 transfection experiments, we determined that a 3 fold
increase in GFP expression in cells over that observed in untreated
cells is the minimal threshold to identify a positive candidate
extract. Wells that showed less than 4,000 cells were discarded as
toxic extracts. 12,000 plant and marine extracts from the NCI
open repository were screened using this protocol.
Isolation of GENK
To Isolate GENK, three grams of the crude extract were
partitioned between EtOAc (3650 mL) and H2O (100 mL). The
combined EtOAc extract was evaporated to dryness to give 2.1 g
of dark green oil; 1.00 g of this was chromatographed on a 10 g
normal phase Waters Sep-PakPak, employing a step gradient from
95:5 n-Hexanes/EtOAc to EtOAc, and from 90:10 EtOAc/
MeOH to MeOH, to give fractions A-E. Fraction C (38 mg)
eluting with 60:40 n-Hexanes/EtOAc, was chromatographed on a
SephadexH LH-20 column using 1:1 MeOH/CH2Cl2 as an eluent
to give fractions C-(A-G). Pure GENK (Figure 2A) (4.9 mg) and a
minor product, genkwanine P (Figure 2C) (2.1 mg) were obtained
aswhite amorphous solids from fraction C-E (15 mg) via C-18
reversed-phase HPLC using 8:2 MeOH/H2O as an eluent over
Cellular Effects of Genkwanine M
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found in the Supplementary Materials S1.
Northern Blot Analysis
Total RNA from cells was purified using TRIzol (Invitrogen).
5 mg of each sample was loaded onto a 1% denaturing agarose gel
(16 MOPS and 20% formaldehyde v/v). RNA was transferred
and crosslinked to Zeta-probe membrane (Bio-Rad, UV Strata-
linker 1800
TM by Strategene). Transfer of RNA was confirmed by
methylene-blue staining. The membrane was pre-hybridized with
5 mL hybridization buffer (0.5 M NaPO4, 10 mM EDTA, 7%
SDS w/v) at 65uC for at least 30 min. [a-
32P] dATP-labeled DNA
probes were generated using the Radprimer kit (Invitrogen) and
subsequently purified using the QIAquick Nucleotide Removal Kit
(Qiagen). For miRNA detection, 20 mg of RNA was loaded onto a
15% denaturing acrylamide gel and subsequently transferred to a
nitrocellulose membrane by a Trans-Blot SD Semi-Dry Transfer
Cell
TM (BioRad) for 1 hr at 12 V. After transfer, RNAs were UV-
crosslinked to the membrane (UV Stratalinker 1800
TM by
Strategene). 59 end-labeled LNA antisense miR-122 or let-7 oligos
(Exiqon) were used for Northern blot analysis. Probes were heated
at 95uC before adding to the pre-hybridized membranes. After
incubating overnight at 65uC, the membranes were washed three
times with 15 mL of Wash Buffer (0.1% SDS w/v, 0.16SSC) at
50uC. The membranes were analyzed by phosphorimager analysis
(Typhoon, GE Healthcare).
In vitro siRNA Cleavage Assay in Rabbit Reticulocyte
Lysate
The miR-451 sensor was constructed by PCR amplification
using primers that amplified the RL gene with the miR-451
sequence in the sense or antisense direction. The PCR product
was subsequently cloned into the pCRII-TOPO vector (Invitro-
gen). The reporter miR-451 RNA was in vitro transcribed by a T7
RNA polymerase reaction. The reporter RNA was dephosphor-
ylated and then 59 end-labeled with [c-
32P]-ATP by T4
polynucleotide kinase (Fermentas). The RNAs were purified using
an RNeasy Kit (Qiagen). Radiolabel RNAs (500,000 cpm) were
incubated in Rabbit Reticulocyte Lysates (Promega) pretreated
with or without 10 mM GENK and aliquots of the reaction were
taken at different times. RNA was extracted from the samples by
phenol/chloroform extraction and ethanol precipitation. Equal
cpm of RNA were loaded on a 12% acrylamide gel, dried, and
analyzed by phosphorimager analysis.
Microarray Analysis
Total RNA extracted from Huh-7 cells pretreated with
DMSO or 10 mM GENK for 1 and 4 hours and performed in
triplicate. Illumina Direct Hybridization assays were performed
by the Vancouver Prostate Centre Laboratory for Advanced
Genome Analysis, Vancouver, Canada. Total RNA quality was
assessed with the Agilent 2100 bioanalyzer prior to microarray
analysis. Samples with a RIN value of greater than or equal to
8.0 were deemed to be acceptable for microarray analysis. An
input of 200 ng of total RNA was used to generate biotin-
labeled cRNA following the IlluminaH TotalPrep RNA Ampli-
fication Kit (Ambion, Inc.). Samples were hybridized on
Illumina HumanHT-12 v3 BeadChips following the Illumina
Whole-Genome Gene Expression Direct Hybridization Assay
Guide (11286331). BeadChips were imaged and quantified with
the Illumina iScan scanner and data was processed with
Illumina BeadStudio v3.3.8. Data processing included averaging
signal intensities for each unique Beadtype. The microarray
data has been deposited to GEO with accession number: (will
be submitted).
Differential expression analysis was carried out between samples
treated with drug for 1 hr and 4 hours relative to untreated
control. log2 normalized expression values were used for statistical
analysis using the limma package in R. The p-values were adjusted
for multiple correction using the Benjamini-Hochberg algorithm.
A stringent criteria consisting of fold change of 2 (up/down-
regulation) and an adjusted p-alue of 0.01 was used to determine
significantly deregulated mRNAs. Clustering of differentially
expressed genes from both treatment groups was carried out
using complete linkage hierarchical clustering with Euclidean
distances with the gplots package in R. Pathway analysis was
performed using the Ingenuity Pathway database. A p-value of
0.05 (-log(p) of 1.30) was used to determine significantly enriched
pathways.
Detection of HCV-infected Cells
A cDNA copy of HCV JFH-1 (a gift from Dr. Takaji Wakita,
National Institute of Infectious Diseases, Tokyo, Japan) was in vitro
transcribed to genomic RNA which was then used to produce
infectious virus stocks as previously described [67,68]. Filtered
HCV JFH-1 stocks were used to infect Huh-7 cells pretreated with
10 mM GENK for 24 hours. At 2 days post-infection, cells were
fixed with 4% v/v formaldehyde in PBS, washed with PBS and
then permeabilized and blocked with PBS containing 3% BSA,
0.3% Triton X and 10% FBS (Blocking buffer) for 1 hr. Cells were
then probed with mouse anti-core C7-50 primary antibody (1:500,
Abcam) in Binding Buffer (Blocking buffer without FBS) at 4uC
overnight then washed 3 times with PBS. Cells were probed with
diluted donkey anti-mouse Alexa-Fluor-568 conjugated secondary
antibody (1:1000) and 10 mg/ml Hoecsht 33258 in binding Buffer
for 1 hr at room temperature. After three washes with PBS, cells
were left in 50 ml PBS and the percentage of HCV infected cells
was analyzed using the Cellomics
TMArrayscan VTI automated
fluorescence imager.
Supporting Information
Figure S1 MTT assay of HeLa and Huh-7 cells treated with
10 mM GENK for the indicated times. Viability of HeLa and
Huh-7 cells (100 mL volume) was monitored by the MTT
colorimetric assay (the addition of final 1.25 mg/mL MTT for 2
hours). Subsequently, cells were lysed with extraction buffer (20%
w/v SDS, 50% DMF, 2.5% acetic acid, and 2.5% 1M HCL)
overnight. Reduction of MTT was detected at 570 nm.
(EPS)
Figure S2 GENK induces SV40 promoter expression of Renilla
luciferase gene. (A) Schematics of SV40 and CMV promoter-
driven expression plasmids that contain Renilla luciferase (RL)
reporter gene alone or with a perfectly complementary binding site
for miR-122 (black rectangle). (B) Northern blot analysis of Huh7
cells transiently transfected with plasmids containing SV40-RL,
SV40-RL-miR122 or CMV-RL incubated with or without 10 mM
GENK for 6 hours. (C) Quantitation of RL and RL-miR-122
mRNA levels normalized to actin in (B). Shown are the averages
from two independent experiments.
(EPS)
Figure S3 GENK effects on siRNA activity using an in vitro
cleavage assay. (A) A fragment of Renilla luciferase was engineered
with a perfectly complementary binding site for miR-451 in the
sense or antisense direction. (B) The miR-451 sensor RNA was in
vitro transcribed as shown and 59end labeled with P
32 using a T4
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lysate (RRL) (Promega) pretreated with DMSO or 10 mM GENK
for the indicated times. Endogenous miR-451 in RRL binds to the
miR-451 site leading to cleavage of the in vitro transcribed RNA to
generate two fragments, 322 and 66 nucleotides in length. Only
the 322 nucleotide fragment will be detected by a phosphorima-
ger. The RNAs were extracted and separated on a 12%
acrylamide gel, which was dried and detected by a phosphor-
imager analysis.
(EPS)
Figure S4 Clustering of differentially expressed mRNAs from 1
and 4 hours treatment groups. Heatmap showing mRNAs that are
differentially expressed at 1 and 4 hours GENK post treatment.
Each mRNA needs to be significantly deregulated in at least one
treatment group to be included. Colors indicate absolute fold
changes according to the specified scale. Red denotes up-
regulation relative to control while blue indicates down-regulation.
Clustering was carried out using the complete linkage clustering
algorithm. Whereas a small number of mRNAs are down-
regulated at 4 hours after treatment, the majority are up-regulated.
(EPS)
Table S1 List of genes up-regulated at 1 hr treatment
with GENK (fold change threshold of 2, adjusted p-value of 0.01).
(DOCX)
Table S2 List of genes up-regulated or down-regulated
at 4 hrs treatment with GENK (fold change threshold of 2,
adjusted p-value of 0.01).
(DOCX)
Table S3 List of genes up-regulated at both 1 and 4
hours treatment with GENK (fold change threshold of 2,
adjusted p-value of 0.01).
(DOCX)
Materials S1
(DOC)
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